Blueprint Medicines Corp Earnings

Blueprint Medicines Corp’s revenue jumped 103.41% since last year same period to $146.37Mn in the Q4 2024. On a quarterly growth basis, Blueprint Medicines Corp has generated 14.18% jump in its revenue since last 3-months.

Blueprint Medicines Corp’s net profit jumped 54.96% since last year same period to $-49.96Mn in the Q4 2024. On a quarterly growth basis, Blueprint Medicines Corp has generated 11.23% jump in its net profits since last 3-months.

Blueprint Medicines Corp’s net profit margin jumped 77.86% since last year same period to -34.13% in the Q4 2024. On a quarterly growth basis, Blueprint Medicines Corp has generated 22.26% jump in its net profit margins since last 3-months.

Blueprint Medicines Corp’s earning per share (EPS) estimates for the current quarter stand at -1.66 - a -132.46% fall from last quarter’s estimates.

Blueprint Medicines Corp’s earning per share (EPS) estimates for the current year stand at -1.66.

Blueprint Medicines Corp’s earning per share (EPS) jumped 56.59% since last year same period to -0.79 in the Q4 2024. This indicates that the Blueprint Medicines Corp has generated 56.59% annual rate of jump in its earning per share (EPS) in the last 4 quarters.